First and only prospective blinded data confirm the Merlin CP-GEP (Clinico pathological-Gene Expression Profiling) Test accurately stratifies melanoma patients by sentinel node metastasis risk, ...
SkylineDx Publishes Landmark MERLIN_001 Trial in JAMA Surgery Validating the Predictive Power of the Merlin CP-GEP Test in Melanoma The issuer is solely responsible for the content of this ...
Scientists discovered that certain blood proteins linked to brain injury and inflammation strongly correlate with early signs of memory and cognitive decline, especially in Hispanic and Latino adults.
SAN ANTONIO, Aug. 5, 2025 /PRNewswire/ -- A groundbreaking multicenter clinical study published on July 30 in JAMA Surgery confirms the powerful diagnostic performance of the Destinex assay, a novel ...
The Bethlehem Area School District is following up on concerns about radon raised in a study published in December. “As a result of the recent interest about radon in schools, BASD decided to include ...
SAN DIEGO, CA, UNITED STATES, June 9, 2025 /EINPresswire.com/ -- The availability of overdose mortality data generally lags by up to 6 months, hindering public health ...
BRISBANE, Calif., June 2, 2025 /PRNewswire/ -- Freenome, a biotechnology company pioneering an early cancer detection platform, today announced the publication of detailed results from the pivotal ...
Comprehensive review confirms that the Oncotype DX Breast Recurrence Score ® test accurately predicts breast cancer outcomes and chemotherapy benefit for patients regardless of race or ethnicity ...
The cancer antigen (CA)-125 test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study found. It's the latest example of medical tests that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback